前收市價 | 37.43 |
開市 | 37.92 |
買盤 | 38.55 x 38700 |
賣出價 | 38.59 x 105300 |
今日波幅 | 37.92 - 39.02 |
52 週波幅 | 30.16 - 49.62 |
成交量 | |
平均成交量 | 467,651 |
市值 | 11.317B |
Beta 值 (5 年,每月) | 無 |
市盈率 (最近 12 個月) | 23.38 |
每股盈利 (最近 12 個月) | 1.65 |
業績公佈日 | 2024年7月30日 |
遠期股息及收益率 | 1.19 (3.18%) |
除息日 | 2024年5月17日 |
1 年預測目標價 | 39.30 |
German healthcare group Fresenius first-quarter results beat expectations, the company said on Wednesday, citing strong performance at its Kabi and Helios businesses, prompting it to raise its full-year outlook. First-quarter earnings before interest and tax (EBIT) were 633 million euros ($680 million), above analysts' expectations of 606 million euros, according to a consensus of forecasts from Vara Research. In a bid to get leaner, Fresenius also said that it would sell its investment unit, Fresenius Vamed, completing its portfolio restructuring.
Medical Device companies' quarterly results are likely to reflect strength in customer demand. Let's see how INSP, MCK, FMS, NVRO and INGN are placed ahead of their earnings releases.
Comfort Systems USA and Boeing are part of the Zacks Bull and Bear of the Day article.